Skip to main content
. 2021 Jun 14;118(25):e2023647118. doi: 10.1073/pnas.2023647118

Fig. 4.

Fig. 4.

Intracellular Salmonella and Yersinia. (A and B) TAK1 inhibition destroys intracellular Salmonella. BMDMs were infected with Salmonella, MOI of 10, and were treated with 300 nM 5ZOZ and/or 3 mM NAC. Cells were incubated with MitoTracker Red at 18 h post infection. Intracellular Salmonella was visualized by immunofluorescence staining of anti-Salmonella. Bottom shows enlarged pictures of the 5ZOZ-treated cell. Yellow arrows indicate damaged Salmonella having no DNA. Yellow asterisk indicates an intact Salmonella cell. (Scale bars, 20 µm in Top and Middle; 5 µm in Bottom.) Quantification of the proportion of damaged intracellular Salmonella is shown in B. Each data point represents one BMDM cell. Data from 30 cells per each treatment in three independent animal-derived BMDMs are shown. (C and D) One YopJ-expressing and two yopJ-deficient Y. enterocolitica strains were infected in BMDMs (MOI of 10). Bacteria colonies of two technical replicate spots from intracellular Yersinia at 18 h post infection with and without 3 mM NAC are shown (C). The bacteria number was quantified at the initial invasion, 30 min (D, left graphs), and at the intracellular maintenance/proliferation phase, 18 h (D, Right graphs). One-way ANOVA, multiple comparisons, and Tukey test (B); unpaired two-way Student’s’ t test (D).